Edit:

Edit Target: 376

pid
Abbr	HT
Name	HydroxyTyrosol
Type
Features

Product : HT, HydroxyTyrosol

Hydroxytyrosol (HT; 3,4-dihydroxyphenylethanol) = phenolic compound from extra-virgin olive oil (EVOO) and olives; also formed from oleuropein metabolism. Small, water-soluble catechol with high antioxidant capacity.
Primary mechanisms (conceptual rank):
1) Direct ROS scavenging + lipid peroxidation inhibition (membrane protection).
2) NRF2 activation → endogenous antioxidant enzymes (HO-1, NQO1, GCLC).
3) Anti-inflammatory modulation (↓ NF-κB, ↓ COX-2, ↓ iNOS).
4) Mitochondrial protection / biogenesis support (model-dependent; PGC-1α linkage reported).
5) Anti-proliferative / pro-apoptotic signaling in cancer (dose- and model-dependent).
PK / bioavailability: well absorbed; rapid phase II metabolism (glucuronide/sulfate conjugates); short plasma half-life; free aglycone concentrations modest vs many in-vitro studies.
In-vitro vs systemic exposure: many cell studies use ≥10–100 µM; typical dietary/EVOO intake yields lower transient plasma levels (conjugated forms predominate).
Clinical evidence status: strongest data in cardiometabolic/vascular endpoints; oncology evidence largely preclinical; neuroprotection mechanistically plausible with limited RCT data.

Hydroxytyrosol is mostly only available from olive oil and leaves, but is available as a common supplement.
Hydroxytyrosol & oleuropein show the most consistent direct anti-CSC activity in multiple models (breast, colon, prostate).

Hydroxytyrosol is potent against CSC phenotypes. Mechanisms: -Blocks EMT, reducing transition into CSC-like states -Inhibits Notch signaling -Reduces CD44+ / CD24– CSC markers -Inhibits hypoxia-driven stemness (HIF-1α suppression) Hydroxytyrosol is especially active in: -Breast CSCs -Melanoma CSC-like cells -Gastric CSC models

Hydroxytyrosol (HT) — Cancer-Relevant Pathways

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation

1 ROS tone / lipid peroxidation ↓ (low–mod dose); ↑ (high concentration only) ↓ P→R Antioxidant; membrane protection Catechol scavenger; at higher concentrations may induce pro-oxidant stress in tumors (model-dependent).

2 NRF2 axis ↑ (context-dependent) ↑ R→G Endogenous antioxidant induction ↑ HO-1/NQO1; protective in normal tissues; could support tumor stress resistance (context-dependent).

3 NF-κB / COX-2 inflammation ↓ ↓ R→G Anti-inflammatory Reduces pro-tumor inflammatory signaling; consistent with Mediterranean diet data.

4 Mitochondrial function ↔ / ↓ proliferation (model-dependent) ↑ (protective) R→G Bioenergetic stabilization Reported support of mitochondrial integrity in normal cells; may impair cancer cell proliferation via metabolic stress.

5 Apoptosis (caspase activation) ↑ (high concentration only) ↔ / ↓ R→G Pro-apoptotic in select tumors Observed at supra-physiologic exposures in vitro.

6 Ferroptosis axis ↓ (anti-lipid-ROS bias) ↓ P→R Inhibits lipid oxidation Strong antioxidant property may counter ferroptotic strategies (context-dependent).

7 Clinical Translation Constraint — — — Exposure limitations Rapid metabolism; plasma free HT lower than many in-vitro doses; best considered dietary adjunct.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr

Hydroxytyrosol (HT) — Cancer Stemness / EMT Axis (Addendum)

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation

1 EMT (Epithelial–Mesenchymal Transition) ↓ (model-/dose-dependent) ↔ R→G Reduces EMT-associated transcription (e.g., Snail, Twist) Reported attenuation of mesenchymal phenotype; relevance strongest in breast and melanoma models; mostly in-vitro.

2 CSC markers (CD44⁺/CD24^–) ↓ (model-dependent) ↔ G Reduces stemness-associated phenotype Observed reduction in CSC-like populations in breast cancer models; requires supra-physiologic exposure in many studies.

3 Notch signaling ↓ (model-dependent) ↔ R→G Stemness pathway inhibition Downregulation of Notch pathway components reported; central to CSC maintenance; not universally replicated across tumor types.

4 HIF-1α / hypoxia-driven stemness ↓ (preclinical) ↔ R→G Suppresses hypoxia adaptation Reduced HIF-1α signaling may attenuate hypoxia-induced CSC traits; data strongest in gastric and breast models.

5 Tumor-type specificity Breast, Melanoma, Gastric (preclinical) — — CSC-like cell sensitivity Evidence largely limited to cell-line and xenograft systems; translational dosing gap remains significant.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr

Hydroxytyrosol (HT) — Alzheimer’s Disease–Relevant Axes

Rank Pathway / Axis Cells (neurons/glia) TSF Primary Effect Notes / Interpretation

1 Lipid peroxidation / neuronal membrane protection ↓ P Neuroprotective antioxidant Protects against oxidative membrane injury; aligns with AD oxidative stress hypothesis.

2 NRF2 activation ↑ R→G Endogenous antioxidant upregulation Supports neuronal resilience under oxidative stress.

3 Neuroinflammation (NF-κB) ↓ R→G Microglial modulation Reduces pro-inflammatory cytokines in models.

4 Mitochondrial integrity ↑ R→G Bioenergetic stabilization Improves mitochondrial function in neuronal models; may reduce apoptotic susceptibility.

5 Aβ toxicity modulation ↓ (preclinical) G Reduces amyloid-induced oxidative injury Animal/cell evidence; limited direct human AD trials.

6 Clinical Translation Constraint — — Dietary-level evidence Human data strongest for Mediterranean diet patterns; isolated HT supplementation lacks large AD RCTs.

TSF Legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr

Home

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	ROS tone / lipid peroxidation	↓ (low–mod dose); ↑ (high concentration only)	↓	P→R	Antioxidant; membrane protection	Catechol scavenger; at higher concentrations may induce pro-oxidant stress in tumors (model-dependent).
2	NRF2 axis	↑ (context-dependent)	↑	R→G	Endogenous antioxidant induction	↑ HO-1/NQO1; protective in normal tissues; could support tumor stress resistance (context-dependent).
3	NF-κB / COX-2 inflammation	↓	↓	R→G	Anti-inflammatory	Reduces pro-tumor inflammatory signaling; consistent with Mediterranean diet data.
4	Mitochondrial function	↔ / ↓ proliferation (model-dependent)	↑ (protective)	R→G	Bioenergetic stabilization	Reported support of mitochondrial integrity in normal cells; may impair cancer cell proliferation via metabolic stress.
5	Apoptosis (caspase activation)	↑ (high concentration only)	↔ / ↓	R→G	Pro-apoptotic in select tumors	Observed at supra-physiologic exposures in vitro.
6	Ferroptosis axis	↓ (anti-lipid-ROS bias)	↓	P→R	Inhibits lipid oxidation	Strong antioxidant property may counter ferroptotic strategies (context-dependent).
7	Clinical Translation Constraint	—	—	—	Exposure limitations	Rapid metabolism; plasma free HT lower than many in-vitro doses; best considered dietary adjunct.

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	EMT (Epithelial–Mesenchymal Transition)	↓ (model-/dose-dependent)	↔	R→G	Reduces EMT-associated transcription (e.g., Snail, Twist)	Reported attenuation of mesenchymal phenotype; relevance strongest in breast and melanoma models; mostly in-vitro.
2	CSC markers (CD44⁺/CD24^–)	↓ (model-dependent)	↔	G	Reduces stemness-associated phenotype	Observed reduction in CSC-like populations in breast cancer models; requires supra-physiologic exposure in many studies.
3	Notch signaling	↓ (model-dependent)	↔	R→G	Stemness pathway inhibition	Downregulation of Notch pathway components reported; central to CSC maintenance; not universally replicated across tumor types.
4	HIF-1α / hypoxia-driven stemness	↓ (preclinical)	↔	R→G	Suppresses hypoxia adaptation	Reduced HIF-1α signaling may attenuate hypoxia-induced CSC traits; data strongest in gastric and breast models.
5	Tumor-type specificity	Breast, Melanoma, Gastric (preclinical)	—	—	CSC-like cell sensitivity	Evidence largely limited to cell-line and xenograft systems; translational dosing gap remains significant.

Rank	Pathway / Axis	Cells (neurons/glia)	TSF	Primary Effect	Notes / Interpretation
1	Lipid peroxidation / neuronal membrane protection	↓	P	Neuroprotective antioxidant	Protects against oxidative membrane injury; aligns with AD oxidative stress hypothesis.
2	NRF2 activation	↑	R→G	Endogenous antioxidant upregulation	Supports neuronal resilience under oxidative stress.
3	Neuroinflammation (NF-κB)	↓	R→G	Microglial modulation	Reduces pro-inflammatory cytokines in models.
4	Mitochondrial integrity	↑	R→G	Bioenergetic stabilization	Improves mitochondrial function in neuronal models; may reduce apoptotic susceptibility.
5	Aβ toxicity modulation	↓ (preclinical)	G	Reduces amyloid-induced oxidative injury	Animal/cell evidence; limited direct human AD trials.
6	Clinical Translation Constraint	—	—	Dietary-level evidence	Human data strongest for Mediterranean diet patterns; isolated HT supplementation lacks large AD RCTs.